Accessibility StatementSkip Navigation SAN DIEGO, Sept. 10, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Lantheus Holdings, Inc. (NASDAQ: LNTH) securities between February 26, 2025 and August 5, 2025, inclusive (the "Class Period"), have until November 10, 2025 to seek appointment as lead plaintiff of the Lantheus class action lawsuit. Captioned Margolis v. Lantheus Holdings, Inc., No. 25-cv- 07491 (S.D.N.Y.), the Lantheus class action lawsuit charges Lanth ...

Core Viewpoint - A securities class action lawsuit has been filed against Lantheus Holdings, Inc. for allegedly providing misleading information to investors regarding the competitive position of its product Pylarify during the class period from February 26, 2025, to August 5, 2025 [1][2]. Group 1 - The lawsuit claims that Lantheus made overwhelmingly positive statements while concealing material adverse facts about Pylarify's competitive dynamics [2]. - It is alleged that the company was not adequately equipped to assess pricing and competition for Pylarify, which led to a risk of price erosion and affected revenue and growth potential [2]. - The complaint states that these misleading statements resulted in shareholders purchasing Lantheus securities at artificially inflated prices [2]. Group 2 - Investors who acquired shares of Lantheus are encouraged to contact the law firm before the lead plaintiff motion deadline on November 10, 2025 [3]. - The lead plaintiff will represent other class members in directing the litigation process [3].

Accessibility StatementSkip Navigation SAN DIEGO, Sept. 10, 2025 /PRNewswire/ -- Robbins LLPÂ informs stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Lantheus Holdings, Inc. (NASAQ: LNTH) securities between February 26, 2025 and August 5, 2025. Lantheus is a global company that develops, manufactures, sells, and distributes certain diagnostic and therapeutic products. The Company's key Radiopharmaceutical Oncology product is Pylarify, a PET i ...

LOS ANGELES--(BUSINESS WIRE)---- $LNTH--LNTH Investors Have Opportunity to Lead Lantheus Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm. ...

ATLANTA, Sept. 10, 2025 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH). The lawsuit alleges, among other things, that Defendants created the false impression that they possessed reliable information pertaining to the Company’s projected revenue outlook and anticipated growth while also minimizing risk from competition and pricing dynamics, seasonality, and macroeconomic fluctuations. If you purchased shares o ...

NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH) between February 26, 2025, to August 5, 2025, both dates inclusive. You are hereby notified that the class action lawsuit Stanley Margolis v. Lantheus Holdings, Inc., et al. (Case No. 1:25-cv-07491) has been commenced in the United States District Court ...

BOSTON, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Block & Leviton announces that a securities fraud lawsuit has been filed against Lantheus Holdings Inc. (Nasdaq: LNTH) and certain of its executives. Investors who have lost money in their Lantheus Holdings Inc. investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://blockleviton.com/cases/lnth. What is this all about? The complaint alleges that Lantheus and its executives misled investors about th ...

Question-and-Answer SessionSo for those in the audience who aren't familiar with the Lantheus story, can you mind just giving me a quick background on the company?Brian MarkisonCEO & Director Yes. So a quick background. Also, please note our safe harbor and forward-looking statements, please. Background on the company, founded coming out of the Manhattan project, had a number of different names over time, but always been in the nuclear medicine business, always leadership going back in time with products li ...

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP reminds investors its investigation on behalf of Lantheus Holdings, Inc. ("Lantheus†or the "Company†) (NASDAQ:LNTH) investors concerning the Company's possible violation of the federal securities laws or other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On August 6, 2025, Lantheus announced disappointing second quarter 2025 results, revealing earnings-per-share ("EPS†) and revenue figures that m. ...

Question-and-Answer SessionSo for those in the audience who aren't familiar with the Lantheus story, can you mind just giving me a quick background on the company?Brian MarkisonCEO & Director Yes. So a quick background. Also, please note our safe harbor and forward-looking statements, please. Background on the company, founded coming out of the Manhattan project, had a number of different names over time, but always been in the nuclear medicine business, always leadership going back in time with products li ...